Get startedLog in
    Picture of Beyond Medical Technologies logo

    DOCT — Beyond Medical Technologies Cashflow Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    FinancialsHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Beyond Medical Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    C2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-5.37-6.52-2.91-1.4-0.552
    Depreciation
    Non-Cash Items2.934.461.380.414-0.026
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-0.0860.0840.1320.0930.076
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Payable / Accrued Expenses
    Other Operating Cash Flow
    Cash from Operating Activities-2.4-1.83-1.4-0.894-0.503
    Capital Expenditures-1.18-0.234———
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items3-0.026-0.4680—
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Other Investing Cash Flow
    Cash from Investing Activities1.82-0.26-0.4680—
    Financing Cash Flow Items——-0.080—
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities0.281-0.0662.6700.03
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-0.297-2.160.807-0.894-0.473